Skip to main content
Fig. 4 | BMC Infectious Diseases

Fig. 4

From: Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use

Fig. 4

Vulnerability to partially-reverted virus after OPV cessation, by serotype and population immunity maintenance scenario. Selected percentiles from the distribution of Rn values for stage 10 OPV-related virus among 520 subpopulations that used OPV-only in 2013 in the global model [4] as a function of time after bOPV cessation for different scenarios of maintenance with bOPV SIAs until bOPV cessation (analysis II; scenarios adopted from Duintjer Tebbens and Thompson 2015 [29]). a Serotype 1, base case (high population immunity maintenance with bOPV). b Serotype 1, medium population immunity maintenance with bOPV. c Serotype 1, low population immunity maintenance with bOPV. d Serotype 3, base case (high population immunity maintenance with bOPV). e Serotype 3, medium population immunity maintenance with bOPV. f Serotype 3, low population immunity maintenance with bOPV

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us